Citation: Ce. Ruhl et Je. Everhart, Relationship of serum leptin concentration and other measures of adipositywith gallbladder disease, HEPATOLOGY, 34(5), 2001, pp. 877-883
Authors:
Schepke, M
Heller, J
Paschke, S
Thomas, J
Wolff, M
Neef, M
Malago, M
Molderings, GJ
Spengler, U
Sauerbruch, T
Citation: M. Schepke et al., Contractile hyporesponsiveness of hepatic arteries in humans with cirrhosis: Evidence for a receptor-specific mechanism, HEPATOLOGY, 34(5), 2001, pp. 884-888
Citation: Pr. John et Pj. Thuluvath, Outcome of liver transplantation in patients with diabetes mellitus: A case-control study, HEPATOLOGY, 34(5), 2001, pp. 889-895
Authors:
Qiao, L
Leach, K
McKinstry, R
Gilfor, D
Yacoub, A
Park, JS
Grant, S
Hylemon, PB
Fisher, PB
Dent, P
Citation: L. Qiao et al., Hepatitis B virus X protein increases expression of p(21Cip-1/WAF1/MDA6) and p(27Kip-1) in primary mouse hepatocytes, leading to reduced cell cycle progression, HEPATOLOGY, 34(5), 2001, pp. 906-917
Authors:
Ichikawa, T
Zhang, YQ
Kogure, K
Hasegawa, Y
Takagi, H
Mori, M
Kojima, I
Citation: T. Ichikawa et al., Transforming growth factor beta and activin tonically inhibit DNA synthesis in the rat liver, HEPATOLOGY, 34(5), 2001, pp. 918-925
Authors:
Redaelli, CA
Wagner, M
Tien, YH
Mazzucchelli, L
Stahel, PF
Schilling, MK
Dufour, JF
Citation: Ca. Redaelli et al., 1 alpha,25-dihydroxycholecalciferol reduces rejection and improves survival in rat liver allografts, HEPATOLOGY, 34(5), 2001, pp. 926-934
Authors:
Fehrenbach, H
Weiskirchen, R
Kasper, M
Gressner, AM
Citation: H. Fehrenbach et al., Up-regulated expression of the receptor for advanced glycation end products in cultured rat hepatic stellate cells during transdifferentiation to myofibroblasts, HEPATOLOGY, 34(5), 2001, pp. 943-952
Authors:
Colell, A
Coll, O
Garcia-Ruiz, C
Paris, R
Tiribelli, C
Kaplowitz, N
Fernandez-Checa, JC
Citation: A. Colell et al., Tauroursodeoxycholic acid protects hepatocytes from ethanol-fed rats against tumor necrosis factor-induced cell death by replenishing mitochondrial glutathione, HEPATOLOGY, 34(5), 2001, pp. 964-971
Authors:
Crenesse, D
Laurens, M
Gugenheim, J
Heurteaux, C
Cursio, R
Rossi, B
Schmid-Alliana, A
Citation: D. Crenesse et al., Intermittent ischemia reduces warm hypoxia-reoxygenation-induced JNK(1)/SAPK(1) activation and apoptosis in rat hepatocytes, HEPATOLOGY, 34(5), 2001, pp. 972-978
Authors:
Wang, B
Cai, SR
Gao, CH
Sladek, FM
Ponder, KP
Citation: B. Wang et al., Lipopolysaccharide results in a marked decrease in hepatocyte nuclear factor 4 alpha in rat liver, HEPATOLOGY, 34(5), 2001, pp. 979-989
Authors:
Kawanaka, H
Tomikawa, M
Jones, MK
Szabo, IL
Pai, R
Baatar, D
Tsugawa, K
Sugimachi, K
Sarfeh, J
Tarnawski, AS
Citation: H. Kawanaka et al., Defective mitogen-activated protein kinase (ERK2) signaling in gastric mucosa of portal hypertensive rats: Potential therapeutic implications, HEPATOLOGY, 34(5), 2001, pp. 990-999
Authors:
Martinot-Peignoux, M
Boyer, N
Cazals-Hatem, D
Pham, BN
Gervais, A
Le Breton, V
Levy, S
Degott, C
Valla, DC
Marcellin, P
Citation: M. Martinot-peignoux et al., Prospective study on anti-hepatitis C virus-positive patients with persistently normal serum alanine transaminase with or without detectable serum hepatitis C virus RNA, HEPATOLOGY, 34(5), 2001, pp. 1000-1005
Authors:
Ferenci, P
Brunner, H
Nachbaur, K
Datz, C
Gschwantler, M
Hofer, H
Stauber, R
Hackl, F
Jessner, W
Rosenbeiger, M
Munda-Steindl, P
Hegenbarth, K
Gangl, A
Vogel, W
Citation: P. Ferenci et al., Combination of interferon induction therapy and ribavirin in chronic hepatitis C, HEPATOLOGY, 34(5), 2001, pp. 1006-1011
Authors:
Lewin, SR
Ribeiro, RM
Walters, T
Lau, GK
Bowden, S
Locarnini, S
Perelson, AS
Citation: Sr. Lewin et al., Analysis of hepatitis B viral load decline under potent therapy: Complex decay profiles observed, HEPATOLOGY, 34(5), 2001, pp. 1012-1020
Citation: S. Nair et Rp. Perrillo, Serum alanine amino transferase flares during interferon treatment of chronic hepatitis B: Is sustained clearance of HBV DNA dependent on levels of pretreatment viremia?, HEPATOLOGY, 34(5), 2001, pp. 1021-1026
Citation: Jl. Hou et al., Prevalence of naturally occurring surface gene variants of hepatitis B virus in nonimmunized surface antigen-negative Chinese carriers, HEPATOLOGY, 34(5), 2001, pp. 1027-1034
Authors:
Sauleda, S
Juarez, A
Esteban, JI
Altisent, C
Ruiz, I
Puig, L
Esteban, R
Guardia, J
Citation: S. Sauleda et al., Interferon and ribavirin combination therapy for chronic hepatitis C in human immunodeficiency virus-infected patients with congenital coagulation disorders, HEPATOLOGY, 34(5), 2001, pp. 1035-1040
Authors:
Boya, P
Larrea, E
Sola, J
Majano, PL
Jimenez, C
Civeira, MP
Prieto, J
Citation: P. Boya et al., Nuclear factor-kappa B in the liver of patients with chronic hepatitis C: Decreased RelA expression is associated with enhanced fibrosis progression, HEPATOLOGY, 34(5), 2001, pp. 1041-1048
Citation: V. Shah, Portal hypertension and the hyperdynamic circulation: Nitric oxide in a haze of cannabinoid smoke (Reprinted from Nat Med, vol 7, 827-832), HEPATOLOGY, 34(5), 2001, pp. 1060-1061
Citation: American Association for the Study of Liver Diseases (AASLD) - 52nd AnnualMeeting and Postgraduate Courses - November 9-13, 2001 - Wyndham Anatole Hotel - Dallas, Texas - Abstracts, HEPATOLOGY, 34(4), 2001, pp. CP1-CP1